Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Sana Biotechnology (NASDAQ:SANA) through any online brokerage.
Other companies in Sana Biotechnology’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Sana Biotechnology has a consensus price target of $7.90.
The stock price for Sana Biotechnology (NASDAQ: SANA) is $2.75 last updated October 6, 2026 at 7:59 PM EDT.
There are no upcoming dividends for Sana Biotechnology.
Sana Biotechnology does not have any upcoming earnings scheduled.
There is no upcoming split for Sana Biotechnology.
Sana Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.